Sign in
The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver
Journal article   Peer reviewed

The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver

Hugo GIRARD, Lyne VILLENEUVE, Michael H COURT, Louis-Charles FORTIER, Patrick CARON, QIN QIN HAO, Lisa L VON MOLTKE, David J GREENBLATT and Chantal GUILLEMETTE
Drug metabolism and disposition, Vol.34(7), pp.1220-1228
2006
Handle:
https://hdl.handle.net/2376/111163
PMID: 16595709

Abstract

Biological and medical sciences Pharmacology. Drug treatments Medical sciences

Metrics

4 Record Views

Details